Ratings Trulieve Cannabis Corp.

Equities

TRUL

CA89788C1041

Market Closed - Canadian Securities Exchange Other stock markets 03:59:42 2024-04-26 pm EDT			5-day change	1st Jan Change
14.37 ^CAD	+4.13%		-3.43%	+109.78%

Apr. 22	Trulieve Cannabis Brief: Opening Medical Cannabis Dispensary in North Palm Beach, Florida	MT
Apr. 22	Trulieve to Open Medical Cannabis Dispensary in North Palm Beach, Florida	CI

Summary

Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

Strengths

Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
Given the positive cash flows generated by its business, the company's valuation level is an asset.
Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
For the past twelve months, EPS forecast has been revised upwards.
Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
The opinion of analysts covering the stock has improved over the past four months.

Weaknesses

According to forecast, a sluggish sales growth is expected for the next fiscal years.
The company has insufficient levels of profitability.
Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Pharmaceuticals

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
TRULIEVE CANNABIS CORP.	+109.78%	2B		C
CURALEAF HOLDINGS, INC.	+23.05%	3.66B		C-
GOODNESS GROWTH HOLDINGS, INC.	+87.30%	61.69M	-	-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes